Plasma nitrotyrosine in reversible myocardial ischaemia. Issue 1 (27th December 2004)

• Record Type: Journal Article
• Authors: Elfatih, A; Anderson, N R; Mansoor, S; Ahmed, S; Horton, R; Holland, M R; Gama, R
• Is Part Of: Journal of clinical pathology. Volume 58:Issue 1(2005)
• Page Start: 95
• Page End: 96
• Publication Date: 2004-12-27
• Subjects: ETT, exercise tolerance test, NO, nitric oxide; nitric oxide -- nitrotyrosine -- peroxynitrite -- reversible myocardial ischaemia -- ischaemic reperfusion injury; Pathology -- Periodicals; Pathology, Molecular -- Periodicals; 616.0705
• DOI: 10.1136/jcp.2004.018713
• Languages: English
• ISSNs: 0021-9746

Abstract

Abstract : Background: Nitric oxide (NO) plays a vital role in vascular homeostasis and in the pathophysiology of coronary heart disease. Its metabolites, nitrite and nitrate, have vasculoprotective properties, whereas peroxynitrite, an oxidant metabolite of NO, is cytotoxic and can aggravate myocardial damage during ischaemic reperfusion injury. Peroxynitrite nitrates free and protein bound tyrosine residues to produce nitrotyrosine. The measurement of nitrotyrosine provides an indirect estimation of plasma peroxynitrite concentrations. Aims: To measure plasma nitrotyrosine concentrations to see whether peroxynitrite could contribute to myocardial dysfunction during myocardial ischaemia induced by an exercise tolerance test (ETT). Materials/Methods: Plasma free nitrotyrosine concentrations were compared before and after exercise in 29 subjects with a positive ETT and 34 subjects with a negative ETT. Results: Plasma nitrotyrosine concentrations were similar in patients with exercise induced myocardial ischaemia and controls. Conclusion: Peroxynitrite does not contribute to the myocardial dysfunction in reversible myocardial ischaemia.